Regression of left ventricular hypertrophy with echocardiography: Some lessons from the live study

Journal of Hypertension

Volumn 21, Issue 1, 2003, Pages 217-221

  Gosse, Philippe ^a   Dubourg, Olivier ^b   Gueret, Pascal ^c  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Echocardiography; Hypertension; Left ventricular hypertrophy; Trials

Indexed keywords

ENALAPRIL; INDAPAMIDE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME;

EID: 0037247576     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200301000-00032     Document Type: Article

References (20)

1. Devereux RB, Agabiti-Rosei E, Dahlof B, Gosse P, Hahn RT, Okin PM, Roman MJ. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens 1996; 14:s95-s102.
2. Schmieder R, Schlaich MP, Klingbail AU, Martus P. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double blind studies until December 1996). Nephrol Dial Transplant 1998; 13:564-569.
3. Cruickshank JM, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy.J Hum Hypertens 1992; 6:85-90.
4. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
5. Devereux RB, Dahlof B, Levy D, Pfeffer MA. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 1996; 78:61-65.
6. Gosse P, Sheridan DJ, Zannad F, Dubourg O, Gueret P, Karpov Y, et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens 2000; 18:1-11.
7. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
8. Gosse P, Guez D, Gueret P, Dubourg O, Beauchet A, de Cordoue A, Barrandon S. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension. J Hypertens 1998; 16:531-535.
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, i:307-310.
10. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents [see comments]. Circulation 1997; 95:2007-2014.
11. Rowlands DB, Glover DR, Ireland MA, McLeay RA, Stallard TJ, Watson RD, Littler WA. Assessment of left-ventricular mass and its response to antihypertensive treatment. Lancet 1982; i:467-470.
12. Gosse P, Durandet P, Roudaut R, Leherissier A, Vrancea F, Dallocchio M. Effect of sotalol on left ventricular mass and function in the hypertensive patient. Arch Mal Coeur Vaiss 1991; 84:1823-1826.
13. Gosse P, Roudaut R, Herrero G, Dallocchio M. Beta-blockers versus angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy. J Cardiovasc Pharmacol 1990; 16:S145-S150.
14. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91:698-706.
15. Herpin D, Demange J. Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass. Quantification and clinical implications. Am J Hypertens 1994; 7:824-828.
16. Palmieri V, Dahlof B, De Quattro V, Sharpe N, Bella JN, de Simone G, et al. Reliability of echocardiographic assessment of left ventricular structure and function. J Am Coll Cardiol 1999; 34:1625-1632.
17. Gottdiener JS, Livengood SV, Meyer PS, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol 1995; 25:424-430.
18. Dai S, Ayres NA, Harrist RB, Bricker JT, Labarthe DR. Validity of echocardiographic measurement in an epidemiological study. Project heartbeat. Hypertension 1999; 34:236-241.
19. de Simone G, Muiesan ML, Ganau A, Longhini C, Verdecchia P, Palmieri V, et al. Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. J Hypertens 1999; 17:1955-1963.
20. Gosse P, Mansour S, Dubourg O, Gueret P, Massonneau M. Semi-automatic measurement of the left ventricular mass from tomodensito-metric traces of the left ventricle. Arch Mal Coeur Vaiss 1999; 92: 961-963.